Clinical Trials Using Selective Human Estrogen-receptor Alpha Partial Agonist TTC-352
Review the clinical trials studying selective human estrogen-receptor alpha partial agonist ttc-352 on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.
You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.